Linas Kaslaukas

Linas J. Kazlauskas, M.D.

  • Assistant Clinical Professor, Department of Radiation Oncology
  • Radiation Oncologist

Linas J. Kazlauskas, M.D.

Clinical Specialties
  • Radiation Oncology
Areas of Expertise
  • 3-D Conformal Radiation Therapy
  • Intensity Modulated Radiation Therapy
  • Image-guided Radiation Therapy
  • MammoSite®
  • Prostate, Breast, Gastrointestinal, Head and Neck, Lung and Skin Cancers
Other Languages Spoken
  • Lithuanian
Dr. Kazlauskas is one of the most patient and informative doctors I have ever met.”  - Patient

With 30 years of radiation oncology experience, Linas Kazlauskas, M.D., brings a broad array of expertise to City of Hope.

Dr. Kazlauskas specializes in the treatment of prostate, breast, gastrointestinal, head and neck, lung and skin cancers. He is well-versed in the latest radiation therapy systems including 3-D conformal radiation therapy, intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

A graduate of Chicago's Loyola University, Dr. Kazlauskas received his medical degree from Rush Medical College and continued his training with a radiation oncology residency at Rush-Presbyterian-St. Luke's Medical Center.

Dr. Kazlauskas makes a point of giving back to the community. He's participated in cancer awareness programs sponsored by the city of Glendale, California, and was interviewed on local TV about long-term health problems caused by the Chernobyl and Fukushima nuclear accidents.
 
  • 2018 - present, Assistant Clinical Professor, Department of Radiation Oncology, Radiation Oncologist, City of Hope, Glendale, CA
  • 2008 - 2018, Medical Director, Vantage Oncology Glendale Radiation Therapy Center, Glendale, CA
  • 2007 - 2008, Radiation Oncologist, Valley Radiotherapy Associates Medical Group at West Hills, CA, Valencia, CA, and Sherman Oaks, CA
  • 2004 - 2007, Radiation Oncologist, Valley Radiotherapy Associates Medical Group at San Bernardino, CA and Riverside, CA
  • 2001 - 2004, Radiation Oncologist, Valley Radiotherapy Associates Medical Group, Wildomar, CA
  • 1994 - 2001, Radiation Oncologist, Valley Regional Oncology Center, Wildomar, CA
  • 1992 - 1993, Radiation Oncologist, Radiation Oncology Centers of Ventura County, Oxnard and Camarillo, CA

Glendale Radiation Oncology

720 E. Colorado Street, Glendale, CA, 91205

Get Directions

Phone :  818-500-5885

Degrees

  • 1988, M.D., Rush Medical College, Chicago IL
  • 1984, B.S. Honors, Loyola University of Chicago, Chicago IL

Residency

  • 1991 - 1992, Chief Resident, Department of Therapeutic Radiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago IL
  • 1988 - 1992, Resident, Radiation Oncology, Department of Therapeutic Radiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago IL
  • Radiation Oncology, American Board of Radiology
Hartsell WF, Sarin P, Recine DC, Kazlauskas LJ, Galinsky DL, Griem KL, Saxena VS, Murthy AK. Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin disease. Radiology 1993; 186:565-568.

Murthy AK, Kazlauskas LJ, Sarin P, Galinsky DL, Saxena VS, Hartsell WH. Control of Hodgkin disease stages I and II: Relationship of radiation dose and time (abstr.) Radiology 1991; 181(P):139.

Martin YC, Danaher EB, Kazlauskas L, Chabalowski C. Comparison of alpha-1, alpha-2, beta-2, and d-2 receptors by computer modeling. Abbott Laboratories C.T.E.C., November 26, 1985.
  • American Society for Therapeutic Radiology and Oncology
  • Southern California Radiation Oncology Society
  • American Medical Association
Back To Top